Bill
Bill > H0446
ID H0446
ID H0446Amends existing law to provide that certain nabiximols shall not be considered Schedule I controlled substances.
summary
Introduced
01/18/2022
01/18/2022
In Committee
02/11/2022
02/11/2022
Crossed Over
01/31/2022
01/31/2022
Passed
03/07/2022
03/07/2022
Dead
Signed/Enacted/Adopted
03/08/2022
03/08/2022
Introduced Session
2022 Regular Session
Bill Summary
CONTROLLED SUBSTANCES -- Amends existing law to provide that certain nabiximols shall not be considered Schedule I controlled substances.
AI Summary
This bill amends existing law to provide that certain nabiximols shall not be considered Schedule I controlled substances. Nabiximols is a drug product containing cannabidiol derived from cannabis with no more than 0.1% residual tetrahydrocannabinols, which has been approved by the United States Food and Drug Administration. By excluding this specific drug product from being classified as a Schedule I controlled substance, the bill aims to facilitate access and use of this medication.
Committee Categories
Government Affairs, Health and Social Services
Sponsors (0)
No sponsors listed
Other Sponsors (1)
Health and Welfare Committee (H)
Last Action
Reported Signed by Governor on March 7, 2022 Session Law Chapter 22 Effective: 07/01/2022 (on 03/08/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://legislature.idaho.gov/sessioninfo/2022/legislation/H0446/ |
| BillText | https://legislature.idaho.gov/wp-content/uploads/sessioninfo/2022/legislation/H0446.pdf |
| Fiscal Note/Analysis - Statement of Purpose / Fiscal Note | https://legislature.idaho.gov/wp-content/uploads/sessioninfo/2022/legislation/H0446SOP.pdf |
Loading...